Author

D. Mercatelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

F. M. Giorgi· 2 shared A. Rakhimov· 1 shared D. Ziegler· 1 shared E. Kasiou· 1 shared E. M. Poursani· 1 shared E. Valli· 1 shared F. Saletta· 1 shared F. T. Michniewicz· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

F. M. Giorgi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Copper chelation inhibits TGF-β pathways and suppresses epithelial-mesenchymal transition in cancer

E. M. Poursani, D. Mercatelli, P. Raninga, J. L. Bell, F. Saletta, F. V. Kohane, Y. Zheng, J. Rouaen, T. R. Jue, F. T. Michniewicz, E. Kasiou, M. Tsoli, G. Cirillo, S. Waters, T. Shai-Hee, , O. VITTORIO

This paper shows copper chelation inhibits TGF-β pathways and reduces EMT in cancer cells, potentially offering a new therapeutic strategy for targeting TGF-β in cancer.

bioRxiv · Oct 3, 2022 · PreprintCancer Biology

Preliminary report on SARS-CoV-2 Spike mutation T478K

S. Di Giacomo, D. Mercatelli, A. Rakhimov, F. M. Giorgi

The paper identifies a novel SARS-CoV-2 Spike mutation T478K in over 11,000 cases, predominantly in Mexico and USA, and tracks its emergence since January 2021.

bioRxiv · Mar 28, 2021Evolutionary Biology